Galecto, Inc. (DMRA) vs Immatics N.V. (IMTX)
Galecto, Inc. and Immatics N.V. are both Biotechnology companies. Galecto, Inc. and Immatics N.V. are of similar size ($1.3B and $1.3B). Galecto, Inc. has the higher net margin (0.00% vs −489.4%) and the higher return on invested capital (0.00% vs −84.8%). Across the 13 metrics below, Galecto, Inc. leads on 10 and Immatics N.V. on 3.
Valuation
Profitability
| Metric | DMRA | IMTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (536.26%) | 0.00% |
| Net margin | 0.00% | (489.35%) | 0.00% |
| Free cash flow margin | 0.00% | (488.01%) | 0.00% |
| Return on equity | (26.26%) | (48.53%) | (57.72%) |
| Return on assets | (18.64%) | (39.83%) | (49.22%) |
| Return on invested capital | 0.00% | (84.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack